Latest Insider Positions

Williamson Thomas P. is listed as an insider in the following companies: ENTL / Entellus Medical, Inc. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.


Security Title Post Shares
ENTL / Entellus Medical VP, Commercial Operations 0

Latest Transactions

Tran Date
Security Code Shares Post Shares Percent
2018-02-28 ENTL / Entellus Medical D -44,986 0 -100.00 24 -1,079,664
2018-01-08 ENTL / Entellus Medical S -1,481 44,986 -3.19 24.12 -35,722 1,085,062 -3.29
2018-01-05 ENTL / Entellus Medical S -968 46,467 -2.04 24.01 -23,242 1,115,673 -2.08
2017-11-04 ENTL / Entellus Medical A 10,000 47,217 26.87
2017-02-04 ENTL / Entellus Medical A 20,000 37,033 117.42
Open market or private purchase of non-derivative or derivative security
Open market or private sale of non-derivative or derivative security
Grant, award, or other acquisition of securities from the company (such as an option)
Conversion of derivative
Sale or transfer of securities back to the company
Payment of exercise price or tax liability using portion of securities received from the company
Gift of securities by or to the insider
Equity swaps and similar hedging transactions
Exercise or conversion of derivative security received from the company (such as an option)
A transaction voluntarily reported on Form 4
Other (accompanied by a footnote describing the transaction)

Peers of Williamson Thomas P. include the following: BAKEWELL JOHN K, BOIANO MARGARET A, BURNHAM JONELLE R, Baltzell Joshua J, Christian Martha J., ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP, ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP, ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP, Essex Woodlands Health Ventures VIII, L.L.C., Essex Woodlands Health Ventures VIII, L.P., Farley Brian E, GRIFFIN THOMAS E, Gonzales Donald A., INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P., INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P., INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P., KOGL JEFF L, MENSINK KEVIN L, MOMTAZEE JAMES C, McCormick Shawn, Milne David Bruce, Moen Brent, NEELS GUIDO J, PAIDOSH STEPHEN R, PETERSON KAREN E, PETRICK TIMOTHY B, Rohlen Douglas, Rosenthal Michael Harry, STRYKER CORP, SUREK JAMES D, SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P., SV LIFE SCIENCES FUND IV, L.P., SVLSF IV, LLC, Split Rock Partners Management LLC, Split Rock Partners, LP, WHITE ROBERT S., . Peers are determined by cross-linking the filings of Williamson Thomas P. with insider filings of others at the same companies.

Related News Stories

Stryker Is One Stock Worth Overpaying For

2018-08-06 seekingalpha
Hip and knee replacement surgeries are expected to increase drastically over the next decade and a half. (2-0)

Will Core Segmental Growth Aid Stryker (SYK) in Q2 Earnings?

2018-07-09 zacks
Stryker Corporation’s (SYK - Free Report) second-quarter 2018 results are scheduled for release on Jul 24, after market close. The company’s acquisition-driven strategy is expected to boost growth by expanding product offerings across all segments. (10-0)

Stryker (SYK) to Acquire SafeAir, Reduce Surgical Smoke

2018-06-28 zacks
Stryker Corporation (SYK - Free Report) recently signed an agreement to acquire SafeAir AG, a Swiss medical device company that provides innovative surgical smoke evacuation solutions. Financial terms related to the deal are still under wraps. (32-0)

Stryker Likely to Acquire Boston Scientific, Shares Down

2018-06-12 zacks
Per a recent report by the Reuters, Stryker Corporation (SYK - Free Report) is likely to take over Boston Scientific Corporation (BSX - Free Report) , creating a market value of more than $110 billion. (52-1)

Here's Why You Should Invest in Stryker (SYK) Stock Now

2018-06-05 zacks
Stryker Corporation (SYK - Free Report) is currently a top performer in the MedTech space. Improved price performance and strong fundamentals instill investors’ confidence in the stock. Therefore, its time you advantage from the stock price appreciation. (30-0)